Monitoring the response to neoadjuvant chemotherapy in patients with breast cancer using ultrasound scattering coefficient: A preliminary report

OBJECTIVE: Neoadjuvant chemotherapy was initially used in locally advanced breast cancer, and currently it is recommended for patients with Stage 3 and with early-stage disease with human epidermal growth factor receptors positive or triple-negative breast cancer. Ultrasound imaging in combination w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobruch-Sobczak, Katarzyna, Piotrzkowska-Wróblewska, Hanna, Klimoda, Ziemowit, Secomski, Wojciech, Karwat, Piotr, Markiewicz-Grodzicka, Ewa, Kolasińska-Ćwikła, Agnieszka, Roszkowska-Purska, Katarzyna, Litniewski, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Exeley Inc. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750328/
https://www.ncbi.nlm.nih.gov/pubmed/31355579
http://dx.doi.org/10.15557/JoU.2019.0013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750328/
https://www.ncbi.nlm.nih.gov/pubmed/31355579
http://dx.doi.org/10.15557/JoU.2019.0013

Ejemplares similares